Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.
(2016) BMC Medical Ethics — Vol. 17, n° 1, p. 63 (2016)
Files
PulfordDJBMCMedEthics2016.pdf
Restricted Access - Adobe PDF
- 637.66 KB
Details
- Authors
- Abstract
- The focus on translational research in clinical trials has the potential to generate clinically relevant genetic data that could have importance to patients. This raises challenging questions about communicating relevant genetic research results to individual patients.
- Affiliations
Citations
Pulford, D. J., Harter, P., Floquet, A., Barrett, C., Suh, D. H., Friedlander, M., Arranz, J. A., Hasegawa, K., Tada, H., Vuylsteke, P., Mirza, M. R., Donadello, N., Scambia, G., Johnson, T., Cox, C., Chan, J. K., Imhof, M., Herzog, T. J., Calvert, P., et al. (2016). Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study. BMC Medical Ethics, 17(1), 63. https://doi.org/10.1186/s12910-016-0144-y (Original work published 2016)